Though the cost of CRM systems varies widely, life sciences companies in particular pay a high price for SaaS software subscription fees – often double or more than what other industries pay.
Leadership today equals leading, managing and constantly adapting to change. Here are some steps to get on a path to change and engage your organization.
Almost every reported concomitant medication has a reason – and many, if not all of these reasons should be reported as adverse events.
Virtus Pharmaceuticals Inc. – a specialty niche pharmaceutical company and part of the Linden Capital Partners portfolio – announced it launched Prometrium (Progesterone, USP Capsules), the company’s first branded product.
Gilead Sciences Inc. announced that two Phase 3b switch studies evaluating Odefsey (emtricitabine 200mg/rilpivirine 25mg/tenofovir alafenamide 25mg) for the treatment of HIV-1 infection met their primary objectives.
Merck said the U.S. Food and Drug Administration has requested the submission of new data and analyses from the MODIFY I and MODIFY II clinical trials previously submitted to the pending Biologics Licensing Application for bezlotoxumab, an investigational agent for prevention of Clostridium difficile (C. difficile) infection recurrence.